Symbol
CLDI on NYSE
Investment type
Equity / Common Stock, $0.0001 par value
Latest Disclosed Ownership
117K shares
Security Ownership
4.99%

Armistice Capital, LLC ownership in Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI)

2025-08-14 - Armistice Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 117K shares of Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI). This represents 4.99% percent ownership of the company.